Childhood myasthenia

Journal of Pediatric Ophthalmology and Strabismus

Volumn 37, Issue 1, 2000, Pages 5-14

  Davitt, Bradley V ^a,b   Fenton, Glen A ^a   Cruz, Oscar A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cardinal Glennon Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; EDROPHONIUM; IMMUNOGLOBULIN; NEOSTIGMINE; PYRIDOSTIGMINE;

ARTICLE; CASE REPORT; CHILDHOOD DISEASE; CHOLINESTERASE INHIBITION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA; NEUROMUSCULAR TRANSMISSION; PRESCHOOL CHILD; PTOSIS; THYMECTOMY;

AMBLYOPIA; BLEPHAROPTOSIS; CHILD, PRESCHOOL; CHOLINESTERASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPHTHALMOPLEGIA; PLASMAPHERESIS; STRABISMUS; SYNAPTIC TRANSMISSION; THYMECTOMY;

EID: 0034092104     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330:1797-1810.
2. Vincent A. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia. Journal of Receptor Research. 1987;7:599-616.
3. Bundey S. A genetic study of infantile and juvenile myasthenia gravis. J Neurol Neurosurg Psychiatry. 1972;35:41-51.
4. Engel AG. Congenital myasthenic syndromes. J Child Neurol. 1988;3:233-246.
5. Fennell DF, Ringle SP. Myasthenia gravis and pregnancy. Obstet Gynecol Surv. 1987;41:414-421.
6. Carr SR, Gilchrist JM, Abuelo DN. Treatment of antenatal myasthenia gravis. Obstet Gynecol. 1991;78:485-489.
7. Shillito P, Vincent A, Newsom-Davis J. Congenital myasthenic syndromes. Neuromuscul Disord. 1993;3:183-190.
8. Uchitel O, Engel AG, Walls TJ, et al. Congenital myasthenic syndromes, II: syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve. 1993;16:1293-1301.
9. Engel AG, Nagel A, Walls TJ, et al. Congenital myasthenic syndromes, 1: deficiency and short open-time of the acetylcholine receptor. Muscle Nerve. 1993;16:1284-1292.
10. Engel AG, Ohno K, Milone M, et al. Congenital myasthenic syndromes. New insights from molecular genetic and patch-clamp studies. Ann NY Acad Sci. 1998;841:140-156.
11. Middleton LT. Congenital myasthenic syndromes. 34th ENMC International Workshop, 10-11 June 1995. Neuromuscul Disord. 1996;6:133-136.
12. Middleton LT, Christodoulou K, Deymeer F, et al. Congenital myasthenic syndrome. CMS type Ia. Clinical and genetic diversity. Ann NY Acad Sci. 1998;841:157-166.
13. Anlar B, Ozdirim E, Renda Y, et al. Myasthenia gravis in childhood. Acta Paediatr. 1996;85:838-842.
14. Namba T, Brunner NG, Brown SB, et al. Familial myasthenia gravis: report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol. 1971;25:49-60.
15. Ohno K, Engel AG. Congenital myasthenic syndromes: gene mutation. Neuromuscul Disord. 1998;8:12-13.
16. Janas JS, Barohn RJ. A clinical approach to the congenital myasthenic syndromes. J Child Neurol. 1995;10:168-169.
17. Engel AG. Congenital myasthenic syndromes. Neurol Clin. 1994;12:401-437.
18. Vincent A, Newsom-Davis J, Wray D, et al. Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann NY Acad Sci. 1993;681:451-460.
19. Andrews PI. A treatment algorithm for autoimmune myasthenia gravis in childhood. Ann NY Acad Sci. 1998;841:789-802.
20. Herrmann DN, Carney PR, Wald JJ. Juvenile myasthenia gravis: treatment with immune globulin and thymectomy. Pediatr Neurol. 1998;18:63-66.
21. Lindner A, Schalke B, Toyka KV. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients. J Neurol. 1997;244:515-520.
22. Batocchi AP, Evoli A, Palmisani MT, et al. Early-onset myasthenia gravis: clinical characteristics and response to therapy. Eur J Pediatr. 1990;150:66-68.
23. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol. 1993;8:403-411.
24. Andrews PI, Massey JM, Howard JF Jr, et al. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology. 1994;44:1208-1214.
25. Dooley JM, Writer H, Gibson EJ, et al. Congenital myasthenia gravis. The clinical spectrum. A practical approach to diagnosis and treatment. Clin Pediatr (Phila). 1988;27:575-578.
26. Fenichel GM. Clinical syndromes of myasthenia in infancy and childhood. A review. Arch Neurol. 1978;35:97-103.
27. Ellenhorn N, Lucchese N, Greenwald M. Juvenile myasthenia gravis and amblyopia. Am J Ophthalmol. 1986;101:214-217.
28. Brodsky MC, Baker RS, Hamed LM. Pediatric Neuro-Ophthalmology. New York, NY: Springer-Verlag; 1996.
29. Verma P, Oger J. Treatment of acquired autoimmune myasthenia gravis: a topic review. Can J Neurol Sci. 1992;19:360-375.
30. Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology. 1993;43:977-982.
31. Roach ES, Buono G, McLean WT Jr, et al. Early-onset myasthenia gravis. J Pediatr. 1986;108:193-197.
32. Tindall RSA. Humoral immunity in myasthenia gravis: effect of steroids and thymectomy. Neurology. 1980;30:554-557.
33. Vial C, Charles N, Chauplannaz G, et al. Myasthenia gravis in childhood and infancy. Usefulness of electrophysiologic studies. Arch Neurol. 1991;48:847-849.
34. Harper CM, Engel AG. Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome. Ann NY Acad Sci. 1998;841:203-206.
35. Harper CM, Engel AG. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol. 1998;43: 480-484.
36. Anlar B, Varli K, Ozdirim E, et al. 3,4-diaminopyridine in childhood myasthenia: double-blind, placebo-controlled trial. J Child Neurol. 1996;11:458-461.
37. Havard CWH, Fonseca V. New treatment approaches to myasthenia gravis. Drugs. 1990;39:66-73.
38. Campbell JR, Bisio JM, Harrison MW, et al. Surgical treatment of myasthenia gravis in childhood. J Pediatr Surg. 1983;18:857-861.
39. Adams C, Theodorescu D, Murphy KG, et al. Thymectomy in juvenile myasthenia gravis. J Child Neurol. 1990;5:215-218.
40. Cavanagh NP. The role of thymectomy in childhood myasthenia. Dev Med Child Neurol. 1980;22:668-670.
41. Youssef S. Thymectomy for myasthenia gravis in children. J Pediatr Surg. 1983;18:537-541.
42. Seybold ME. Thymectomy in childhood myasthenia gravis. Ann NY Acad Sci. 1998;841:731-741.
43. Rodriguez M, Gomez MR, Howard FM Jr, et al. Myasthenia gravis in children: long-term follow-up. Ann Neurol. 1983;13:504-510.
44. Pescarmona E, Giardini R, Brisigotti M, et al. Thymoma in childhood: a clinicopathological study of five cases. Histopathology. 1992;21:65-68.
45. Furman WL, Buckley PI, Green AA, et al. Thymoma and myasthenia gravis in a 4-year-old child. Case report and review of the literature. Cancer. 1985;56:2703-2706.
46. Badurska B, Ryniewicz B, Strugalska H. Immunosuppressive treatment for juvenile myasthenia gravis. Eur J Pediatr. 1992;151:215-217.
47. Berkovitz S, Belkin M, Tenenbaum A. Childhood myasthenia gravis. J Pediatr Ophthalmol. 1977;14:269-273.